Baker Bros. Advisors LP 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:21 pm Purchase | 2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX | Baker Bros. Advisors LP | 6,751,565 9.700% | 1,799,113 (+36.33%) | Filing |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Baker Bros. Advisors LP | 4,952,452 9.990% | 150,498 (+3.13%) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Baker Bros. Advisors LP | 4,801,954 9.990% | 2,347,872 (+95.67%) | Filing |
| 2022-02-14 4:15 pm Purchase | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Baker Bros. Advisors LP | 2,454,082 5.500% | 2,454,082 (New Position) | Filing |